Sitahenz-M OD Tablet SR

Sitahenz-M OD Tablet SR is a prescription diabetes medicine that combines sitagliptin and metformin in each sustained-release tablet. It belongs to the DPP-4 inhibitor plus biguanide drug classes and is used to help lower blood sugar in adults with type 2 diabetes. Sitahenz-M OD Tablet SR is not for type 1 diabetes or diabetic ketoacidosis. Because it is an SR tablet, it is designed to release medicine slowly over time.

How it works: Sitagliptin helps the body release more insulin after meals and lowers the hormone that raises blood sugar. Metformin lowers the amount of sugar made by the liver and helps the body use insulin better, while the SR tablet releases the medicine gradually over time.

Sitahenz-M OD Tablet SR is the sustained-release, once-daily-style tablet in this brand family, while Sitahenz-M 1000 Tablet SR is the other listed sibling strength. The exact labelled ingredient amounts in Sitahenz-M OD Tablet SR should be checked on the carton or strip, and this product is chosen by a doctor when a slower-release combination tablet is appropriate for a person’s glucose control and treatment plan. Compared with lower-strength tablets, this form may be used when a clinician wants the same two-medicine combination in a tablet suited to a higher maintenance dose.

• Type 2 diabetes
• Blood sugar control
• Add-on therapy with diet and exercise
• Combination treatment when a single medicine is not enough

• Swallow the Sitahenz-M OD Tablet SR whole with water; do not crush, chew, or split it.
• Take it exactly as prescribed by your doctor, usually with food to reduce stomach upset.
• Take it at the same time each day if your prescriber has told you to use it once daily.
• Do not use more tablets or take extra doses to make up for a missed dose unless your doctor tells you to.
• Keep following your diabetes meal plan, exercise plan, and blood sugar monitoring instructions while taking this tablet.

Sitahenz-M OD Tablet SR provides the exact labelled dose of sitagliptin plus metformin in each sustained-release tablet; the strength is intended for patients whose doctor has already decided this combination and release pattern fit their needs. Depending on the prescribed regimen and the product strength, it may be taken once daily, and the maximum number of tablets per day depends on the doctor’s directions and the total metformin/sitagliptin amount needed. Do not change the dose on your own, because this product should be individualized based on blood sugar response, kidney function, and tolerability.

Do not change your dose or stop the medicine without speaking to your doctor.

Common side effects of Sitagliptin + Metformin may include:

• Nausea
• Diarrhea
• Stomach upset
• Gas or bloating
• Headache
• Cold-like symptoms
• Low blood sugar if used with insulin or a sulfonylurea

• This is a higher-strength combination tablet that should be used only when a clinician has reviewed your diabetes control and kidney function.
• Do not take it if you have type 1 diabetes or diabetic ketoacidosis.
• Avoid heavy alcohol use, because metformin can raise the risk of lactic acidosis.
• Tell your doctor if you have kidney disease, liver disease, heart failure, or a history of pancreatitis.
• If you take insulin or a sulfonylurea, your risk of low blood sugar may be higher.
• Seek medical advice before surgery, X-ray contrast studies, or major illness, since metformin may need to be held temporarily.
• Do not drive or operate machinery if you have dizziness or low blood sugar.

• Insulin or sulfonylureas, which can increase low blood sugar risk
• Alcohol, which can increase the risk of metformin-related lactic acidosis
• Iodinated contrast dye used in some imaging tests
• Cimetidine and some other medicines that may affect metformin levels
• Other diabetes medicines that may change glucose control

Store Sitahenz-M OD Tablet SR in its original strip or box at room temperature, away from moisture, heat, and direct light.